CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B 期刊论文
HEPATOLOGY RESEARCH, 2018, 卷号: 48, 期号: 3
作者:  Yu, Rui;  Tan, Deming;  Ning, Qin;  Niu, Junqi;  Bai, Xuefan
收藏  |  浏览/下载:28/0  |  提交时间:2019/12/05
Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China 期刊论文
ACTA HAEMATOLOGICA, 2016, 卷号: 136, 期号: 4
作者:  Gong, Dan;  Li, Wei;  Hu, Liang-Ding;  Shen, Jian-Liang;  Fang, Mei-Yun
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study 期刊论文
HEPATOLOGY, 2014, 卷号: 59, 期号: 4
作者:  Bai, Xuefan;  Sun, Jian;  Xie, Qing;  Tan, Deming;  Ning, Qin
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 期刊论文
HEPATOLOGY, 2013, 卷号: 58
作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文
作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace